265 related articles for article (PubMed ID: 33586832)
1. "Helicobacter pylori in familial mediterranean fever: A series of 120 patients from literature and from france".
Lacout C; Savey L; Bourguiba R; Giurgea I; Amselem S; Hoyeau N; Galland J; Amiot X; Grateau G; Ducharme-Bénard S; Georgin-Lavialle S
Helicobacter; 2021 Apr; 26(2):e12789. PubMed ID: 33586832
[TBL] [Abstract][Full Text] [Related]
2. Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients.
Haj Yahia S; Ben Zvi I; Livneh A
Rheumatol Int; 2018 Jan; 38(1):141-147. PubMed ID: 28975396
[TBL] [Abstract][Full Text] [Related]
3. Co-existence of Helicobacter pylori infection in patients with Familial Mediterranean Fever (FMF) and the effect of Helicobacter pylori on the frequency and severity of FMF attacks.
Demirtürk L; Ozel AM; Cekem K; Yazgan Y; Gultepe M
Dig Liver Dis; 2005 Mar; 37(3):153-8. PubMed ID: 15888278
[TBL] [Abstract][Full Text] [Related]
4. Effect of Helicobacter pylori infection and eradication therapy on interleukin-6 levels in patients with Familial Mediterranean Fever.
Ozel AM; Demirturk L; Aydogdu A; Gultepe M; Yazgan Y; Imirzalioglu N; Gurbuz AK; Narin Y
Int J Clin Pract; 2008 May; 62(5):754-61. PubMed ID: 17343670
[TBL] [Abstract][Full Text] [Related]
5. Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori.
Cohen O; Locketz G; Hershko AY; Gorshtein A; Levy Y
Rheumatol Int; 2015 Nov; 35(11):1937-41. PubMed ID: 26210999
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of hearing in pediatric familial Mediterranean fever patients during attack period and attack-free period.
Salimov A; Akyol U; Cildir B; Batu ED; Ozen S
Int J Pediatr Otorhinolaryngol; 2019 Apr; 119():185-192. PubMed ID: 30743166
[TBL] [Abstract][Full Text] [Related]
7. [Familial Mediterranean Fever (FMF): from diagnosis to treatment].
Medlej-Hashim M; Loiselet J; Lefranc G; Mégarbané A
Sante; 2004; 14(4):261-6. PubMed ID: 15745878
[TBL] [Abstract][Full Text] [Related]
8. Familial Mediterranean fever in childhood: a single-center experience.
Barut K; Sahin S; Adrovic A; Sinoplu AB; Yucel G; Pamuk G; Aydın AK; Dasdemir S; Turanlı ET; Buyru N; Kasapcopur O
Rheumatol Int; 2018 Jan; 38(1):67-74. PubMed ID: 28828621
[TBL] [Abstract][Full Text] [Related]
9. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
Kurt T; Aydın F; Nilüfer Tekgöz P; Sezer M; Uncu N; Çelikel Acar B
Int J Rheum Dis; 2020 Jul; 23(7):977-981. PubMed ID: 32558310
[TBL] [Abstract][Full Text] [Related]
10. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health.
Samuels J; Aksentijevich I; Torosyan Y; Centola M; Deng Z; Sood R; Kastner DL
Medicine (Baltimore); 1998 Jul; 77(4):268-97. PubMed ID: 9715731
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal mucosal involvement without amyloidosis in children with familial Mediterranean fever.
Gurkan OE; Dalgic B
J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):319-23. PubMed ID: 23591909
[TBL] [Abstract][Full Text] [Related]
12. Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review.
Eren Akarcan S; Dogantan S; Edeer Karaca N; Aksu G; Kutukculer N
Rheumatol Int; 2020 Jan; 40(1):161-168. PubMed ID: 31273456
[TBL] [Abstract][Full Text] [Related]
13. Association between familial Mediterranean fever and multiple sclerosis: A case series from the JIR cohort and systematic literature review.
Elhani I; Dumont A; Vergneault H; Ardois S; Le Besnerais M; Levesque H; Ouallet JC; Savey L; Aouba A; Amselem S; Giurgea I; Capron J; Grateau G; Georgin-Lavialle S
Mult Scler Relat Disord; 2021 May; 50():102834. PubMed ID: 33609923
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
[TBL] [Abstract][Full Text] [Related]
15. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
Şahin A; Derin ME; Albayrak F; Karakaş B; Karagöz Y
Adv Rheumatol; 2020 Jan; 60(1):12. PubMed ID: 32000860
[TBL] [Abstract][Full Text] [Related]
16. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
Omma A; Sandikci SC; Kücüksahin O; Alisik M; Erel O
J Korean Med Sci; 2017 Oct; 32(10):1588-1594. PubMed ID: 28875601
[TBL] [Abstract][Full Text] [Related]
17. Familial Mediterranean Fever (FMF): a single centre retrospective study in Amsterdam.
Hageman IMG; Visser H; Veenstra J; Baas F; Siegert CEH
Neth J Med; 2019 Jun; 77(5):177-182. PubMed ID: 31264586
[TBL] [Abstract][Full Text] [Related]
18. MEFV gene compound heterozygous mutations in familial Mediterranean fever phenotype: a retrospective clinical and molecular study.
Caglayan AO; Demiryilmaz F; Ozyazgan I; Gumus H
Nephrol Dial Transplant; 2010 Aug; 25(8):2520-3. PubMed ID: 19934083
[TBL] [Abstract][Full Text] [Related]
19. Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.
Portincasa P; Scaccianoce G; Palasciano G
Eur J Clin Invest; 2013 Dec; 43(12):1314-27. PubMed ID: 24117178
[TBL] [Abstract][Full Text] [Related]
20. A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever.
Corsia A; Georgin-Lavialle S; Hentgen V; Hachulla E; Grateau G; Faye A; Quartier P; Rossi-Semerano L; Koné-Paut I
Orphanet J Rare Dis; 2017 Mar; 12(1):54. PubMed ID: 28302131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
